This Week in Cardiology cover image

Mar 10 2023 This Week in Cardiology

This Week in Cardiology

00:00

Is There Evidence for Statin Intolerance?

The PI of clear outcomes made two references during the presentation to a packed house in the main ballroom. NexLivit is a combination drug of vampadolic and azidomum. The company that makes it, I looked up, is Asperion; they sponsored the clear outcomes trial. We should resist the urge to easily succumb to more expensive drugs with far less evidence for benefit.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app